Literature DB >> 11096561

Biliary Tract Dysmotility.

.   

Abstract

Biliary pain resulting from motility disorders is common and may be overlooked due to the difficulty of diagnosing the presence of these disorders. A sound, logical approach to the evaluation and treatment of these specific groups of disorders is essential. In patients who have a gallbladder, we initially exclude the presence of gallstones by use of transcutaneous ultrasonography. If a patient's symptoms are atypical, we initiate therapy (eg, antispasmodics) for irritable bowel syndrome. Subsequently, we perform a quantitative cholescintigraphy with a low-dose infusion of cholecystokinin in patients with typical symptoms and in those with persistent atypical symptoms. Those patients who have abnormally low gallbladder ejection fractions are subsequently referred for laparoscopic cholecystectomy. In postcholecystectomy patients, a standard approach should include obtaining serum liver associated laboratory chemistries, amylase and lipase levels, and a transcutaneous ultrasound to measure bile duct size. Endoscopic retrograde cholangiopancreatography (ERCP) is done to measure bile duct size, assess biliary duct emptying, and exclude other etiologies for pain. In patients with more than two abnormal findings on these tests (type I sphincter of Oddi dyskinesia), we recommend performing an empiric endoscopic biliary sphincterotomy. In patients with no objective abnormalities (type III sphincter of Oddi dyskinesia), it is appropriate to begin medical therapy with antispasmodics and calcium-channel antagonists. In individuals who have one or two abnormalities (type II sphincter of Oddi dyskinesia) we prefer endoscopic biliary sphincterotomy; however, these individuals are offered the opportunity to have endoscopic biliary manometry performed in order to establish a clear diagnosis. If patients refuse this procedure, after careful explanation of risks, alternatives, and possible benefits of the procedure, empiric endoscopic biliary sphincterotomy is performed.

Entities:  

Year:  1998        PMID: 11096561     DOI: 10.1007/s11938-998-0005-y

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  37 in total

1.  Treatment of biliary colic with diclofenac: a randomized, double-blind, placebo-controlled study.

Authors:  E A Akriviadis; M Hatzigavriel; D Kapnias; J Kirimlidis; A Markantas; A Garyfallos
Journal:  Gastroenterology       Date:  1997-07       Impact factor: 22.682

2.  Topical glyceryl trinitrate relaxes the sphincter of Oddi.

Authors:  W Luman; A Pryde; R C Heading; K R Palmer
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

3.  Beneficial effect of lovastatin on sphincter of Oddi dyskinesia in hypercholesterolemia and hypertriglyceridemia.

Authors:  Z Szilvássy; I Nagy; L Madácsy; F Hajnal; B Velösy; T Takács; J Lonovics
Journal:  Am J Gastroenterol       Date:  1997-05       Impact factor: 10.864

4.  Effect of cisapride on gallbladder motility after extracorporeal shock-wave lithotripsy.

Authors:  J Thorens; J F Schnegg; R Brignoli; F Froehlich; J B Jansen; G Dorta; A L Blum; J J Gonvers; M Fried
Journal:  J Hepatol       Date:  1995-03       Impact factor: 25.083

5.  Nifedipine for suspected type II sphincter of Oddi dyskinesia.

Authors:  M S Khuroo; G N Yattoo; B A Khan; H S Altaf
Journal:  Am J Gastroenterol       Date:  1994-07       Impact factor: 10.864

6.  Does intrabiliary pressure predict basal sphincter of Oddi pressure? A study in patients with and without gallbladders.

Authors:  A N Kalloo; T G Tietjen; P J Pasricha
Journal:  Gastrointest Endosc       Date:  1996-12       Impact factor: 9.427

Review 7.  Overview of therapeutic modalities for the treatment of gallstone diseases.

Authors:  S M Strasberg; P A Clavien
Journal:  Am J Surg       Date:  1993-04       Impact factor: 2.565

8.  Efficacy of nifedipine therapy in patients with sphincter of Oddi dysfunction: a prospective, double-blind, randomized, placebo-controlled, cross over trial.

Authors:  M S Khuroo; S A Zargar; G N Yattoo
Journal:  Br J Clin Pharmacol       Date:  1992-05       Impact factor: 4.335

9.  The role of gallbladder emptying in gallstone formation during diet-induced rapid weight loss.

Authors:  R L Gebhard; W F Prigge; H J Ansel; L Schlasner; S R Ketover; D Sande; K Holtmeier; F J Peterson
Journal:  Hepatology       Date:  1996-09       Impact factor: 17.425

10.  Influence of spasmolytic analgesics on motility of sphincter of Oddi.

Authors:  G Brandstätter; S Schinzel; H Wurzer
Journal:  Dig Dis Sci       Date:  1996-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.